Yes, you may travel with a prescription supply of Stromectol, but it is advisable to carry the original pharmacy label and a copy of your prescription. Some countries may require proof of prescription at the border, so keeping documentation handy can prevent delays.
Ivermectin is not listed as a prohibited substance by the World Anti-Doping Agency (WADA) for athletes, nor is it commonly screened for in standard occupational drug tests. However, disclose any medication use to your employer or sports governing body if required.
In the UK, the 3 mg tablet is white and round, the 6 mg tablet is white and oval, and the 12 mg tablet is white, round, and bears the imprint “IVM 12 MSD”. Appearance may vary slightly by batch, but dosage markings are consistent.
Stromectol is a branded formulation of the active ingredient ivermectin. The generic version contains the same compound in identical strengths and is therapeutically equivalent, though inactive ingredients (excipients) may differ.
Ivermectin is generally not recommended for children weighing less than 15 kg or younger than five years, except in severe scabies where the benefits may outweigh the risks. Pediatric dosing should be determined by a pediatrician.
Ivermectin absorption can increase slightly when taken with a high-fat meal, but this effect is not clinically significant. You may take the tablet with or without food; choose the option that minimizes gastrointestinal discomfort.
Do not use tablets past the printed expiry date. Chemical stability cannot be guaranteed beyond this point, and efficacy may be reduced. If you possess expired medication, discard it safely according to NHS guidelines.
Brand-name Stromectol may be priced higher than generic ivermectin due to branding and packaging. NHS prescription charges apply uniformly, but private purchases can vary. Discuss pricing options with your pharmacist.
Stromectol is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA). Clinical guidelines for its use are provided by NICE and the British Society for Antimicrobial Chemotherapy (BSAC).
Current high-quality clinical evidence does not support the use of ivermectin for preventing or treating COVID-19. Major health agencies, including the MHRA and WHO, advise against its routine use for this purpose outside of a controlled trial.
Stromectol is a prescription-only medication marketed in the United Kingdom under the brand name Stromectol. Its single active ingredient is ivermectin, an antiparasitic agent that belongs to the macrocyclic lactone class. Stromectol is supplied as oral tablets (pill form) in three strengths: 3 mg, 6 mg, and 12 mg. The product is manufactured by Merck Sharp & Dohme (MSD) and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). While ivermectin is approved for several parasitic infections, its use for COVID-19 remains investigational and is not endorsed by UK authorities.
Ivermectin exerts its antiparasitic effect by binding selectively to glutamate-gated chloride channels found in the nerve and muscle cells of many invertebrates. This binding increases the flow of chloride ions into the cells, causing hyperpolarisation, paralysis, and ultimately death of the parasite. Human cells lack these specific channels, which accounts for the drug’s relatively high safety margin when used at approved doses.
For the few viruses that have been studied in the laboratory, ivermectin appears to inhibit replication by interfering with the import of viral proteins into the host cell nucleus (a process mediated by the importin α/β pathway). These antiviral mechanisms have been demonstrated only in cell-culture experiments; clinical relevance in humans, including for SARS-CoV-2, has not been established.
Stromectol is authorised in the UK for the following indications:
The choice of dose and treatment duration depends on the specific infection, the patient’s weight, and any comorbid conditions. Ivermectin is not approved for the prevention or treatment of COVID-19 by the MHRA, the National Institute for Health and Care Excellence (NICE), or any other UK regulatory body.
During the COVID-19 pandemic, ivermectin was evaluated in several laboratory studies and clinical trials as a potential antiviral agent. To date:
Off-label disclaimer: Use of Stromectol for COVID-19 is considered off-label and should only occur within the context of a supervised clinical trial or after a detailed risk-benefit discussion with a qualified healthcare professional.
| Interaction Level | Example Drugs | Clinical Note |
|---|---|---|
| Major | Warfarin - theoretical increase in anticoagulant effect; monitor INR. | |
| Moderate | Cytochrome P450 3A4 inhibitors (e.g., ketoconazole, clarithromycin) - may raise ivermectin levels; consider dose adjustment. | |
| Minor | Other antiparasitics - additive central nervous system effects; avoid unnecessary combination. |
Patients should disclose all prescription medicines, over-the-counter products, herbal supplements, and vitamins before starting Stromectol.
| Indication | Typical Adult Dose* | Tablet Strength Used | |||-| | Strongyloidiasis | 200 µg/kg as a single dose (≈12 mg for a 60 kg adult) | 12 mg tablet | | Onchocerciasis | 150 µg/kg once, repeated after 6-12 months | 6 mg or 12 mg tablets | | Scabies (adults) | 200 µg/kg on day 1 and repeated after 7 days | 12 mg tablet | | Lice | 200 µg/kg single dose | 12 mg tablet |
*Doses are weight-based; tablets can be split under pharmacy guidance to achieve the appropriate amount.
If you forget a dose and are within 12 hours of the scheduled time, take it as soon as you remember. If it is later than 12 hours, skip the missed dose and resume your regular schedule. Do not double-dose without professional advice.
Signs of ivermectin overdose may include severe dizziness, tremor, ataxia, or seizures. In the event of suspected overdose:
Therapy is usually short-term; abrupt cessation is not an issue. If a severe adverse reaction occurs, discontinue the medication and contact a healthcare professional promptly.
Routine laboratory monitoring is not required for uncomplicated infections in otherwise healthy adults.
This article provides educational information about Stromectol and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
